Montecucco, Fabrizio

 
Title Year Hits Downloads
Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients 2018 39 1
4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability 2017 110 2
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 2017 12 0
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms 2017 30 6
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population 2017 34 0
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments 2016 197 3
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study 2016 163 6
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes 2016 186 6
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 2016 149 0
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis 2016 282 1
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 300 136
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 2016 31 2
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 2016 168 1
Potential useful prognostic parameters after transcatheter aortic valve implantation: editorial 2016 95 1
Prognostic value of PCSK9 levels in patients with acute coronary syndromes 2016 211 2
Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 2016 220 3
Role of Neutrophils in Atherogenesis: an Update 2016 140 2
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation 2016 158 0
Protective role of necrostatin-1 in acute myocardial infarction 2015 108 0
Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions 2015 269 0
Update on the role of neutrophils in atherosclerotic plaque vulnerability 2015 129 0
Leptin/adiponectin ratio predicts post-stroke neurological outcome 2015 168 1
Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo study 2015 167 0
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways 2015 277 2
Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis 2015 137 0
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15 2015 157 0
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 2015 176 4
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways 2015 305 0
Evidence on the protective role of high-density lipoprotein (HDL) in HIV-infected individuals 2015 310 0
Inflammation in arterial diseases 2015 117 0
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population 2015 251 0
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells 2015 141 0
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury 2015 169 0
Clinical relevance of adverse intracerebral artery remodeling in patients with HIV. 2015 99 0
Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction 2015 204 3
Editorial: is ischemic stroke an inflammatory disease? 2015 88 0
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 2015 195 0
Editorial: update on inflammatory targets modulating atherogenesis 2015 127 0
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice 2015 182 0
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways 2015 321 4
Emerging pathophysiological relevance for neutrophils in acute coronary syndromes 2015 111 0
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 2015 264 0
CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes 2015 213 1
Treatment with apixaban in a patient with recent chronic subdural haematoma: a case report 2015 133 36
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 2015 203 0
The role of adipocytokines in atherogenesis and atheroprogression 2015 138 0
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury 2015 233 42
Role of matrix metalloproteinases in animal models of ischemic stroke 2015 142 0
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study 2015 169 0
Update on strategies limiting iatrogenic hypoglycemia 2015 118 29
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 2015 172 1
Reply to "precipitants of heart failure must be fully considered when predicting readmission" 2014 262 0
Immunological aspects of atherosclerosis 2014 235 0
Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis 2014 222 0
Update on the efficacy of statin treatment in acute coronary syndromes 2014 190 0
Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke 2014 230 0
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis 2014 316 134
Inferior vena cava parameters predict re-admission in ischaemic heart failure 2014 203 0
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients 2014 171 0
Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice 2014 284 157
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis 2014 213 0
Carotid atherosclerotic plaque stenosis: the stabilizing role of statins 2014 199 0
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases 2014 374 0
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques 2014 171 0
Potential pathophysiological role for the vitamin D deficiency in essential hypertension 2014 202 0
Angiotensin II receptor antagonists in acute coronary syndromes 2014 143 0
Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose 2014 119 23
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes 2014 137 0
Advanced glycation end products play adverse proinflammatory activities in osteoporosis 2014 165 349
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity 2014 162 0
Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways 2014 160 0
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity 2014 245 62
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice 2014 268 0
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes 2013 154 155
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia 2013 164 0
Role of the renin-angiotensin system on abdominal aortic aneurysms 2013 135 0
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines 2013 232 0
Role of matrix metalloproteinase-8 in atherosclerosis 2013 151 31
Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum 2013 162 0
Update on evidence for treatment with ranolazine in stable angina 2013 126 0
Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongation 2013 141 0
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice 2013 109 1
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome 2013 137 0
What happened to a thrombus during apical ballooning syndrome: a case report 2013 138 0
The vulnerable coronary plaque: update on imaging technologies 2013 89 0
Chronic myeloid leukemia: reaching for the cure 2013 79 0
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice 2013 234 0
Pathophysiological role of neutrophils in acute myocardial infarction 2013 170 0
Inflammation is a key pathophysiological feature of metabolic syndrome 2013 148 45
Autophagy in blood cancers: biological role and therapeutic implications 2013 148 0
Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases 2013 264 2
Pathophysiological role of the renin-angiotensin system on erectile dysfunction 2013 153 77
Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity 2013 170 39
Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1) 2013 183 49
Update on the protective molecular pathways improving pancreatic beta-cell dysfunction 2013 204 44
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury 2013 207 0
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice 2013 317 0
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome 2013 170 42
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience 2013 200 0
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer 2013 136 37
The role of the intraplaque vitamin d system in atherogenesis 2013 121 54
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy 2013 290 0
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma 2013 178 0
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases 2013 105 0
Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice 2013 111 0
Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders 2013 133 0
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm" 2013 78 0
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction 2013 328 372
Role of renin-angiotensin system in inflammation, immunity and aging 2012 205 0
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques 2012 293 2
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury 2012 211 0
Update on the evidence of statin treatment to reduce plaque vulnerability 2012 199 0
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer 2012 146 0
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation 2012 147 0
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice 2012 283 3
Inflammatory cardiovascular risk biomarkers: update on novelties and limitations 2012 153 0
Statins in the treatment of acute ischemic stroke 2012 155 0
Role of cytokines and chemokines in non-alcoholic fatty liver disease 2012 63 0
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction 2012 92 0
Elevated E-selectin and diastolic blood pressure in diabetic children 2012 255 0
Inhibition of the renin-angiotensin-aldosterone system: how to obtain this 2012 141 0
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium 2012 163 0
Serum resistin and inflammatory and endothelial activation markers in obese adolescents 2012 253 0
Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injury 2012 138 0
Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals 2012 226 85
Update on the role of cannabinoid receptors after ischemic stroke 2012 146 1
Coronary Vasomotor Control in Obesity and Morbid Obesity 2012 307 322
The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases 2012 81 0
Statins and stent thrombosis 2012 142 0
Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability 2012 333 1
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology 2012 211 0
Molecular imaging of matrix metalloproteinases in atherosclerotic plaques 2012 102 0
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity 2011 275 0
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 2011 246 2
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome 2011 258 0
Novel treatment strategy with direct renin inhibition against heart failure 2010 207 0
Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification 2010 349 0
New evidence for nicotinic acid treatment to reduce atherosclerosis 2010 658 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 285 2
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS) 2010 241 1
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling 2010 221 0
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke 2010 255 0
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice 2010 255 0
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes 2009 252 0
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways 2009 197 0
Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin 2009 298 0
Ezetimibe/simvastatin 2009 173 0
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury 2009 220 0
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies 2009 226 0
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk 2009 164 0
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis 2009 235 0
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial 2009 285 0
Statins, ACE inhibitors and ARBs in cardiovascular disease 2009 212 0
Update on statin-mediated anti-inflammatory activities in atherosclerosis 2009 199 1
Atherosclerosis is an inflammatory disease 2009 188 1
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis 2009 234 5
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome 2009 229 0
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion 2009 298 0
Cannabinoid receptors in acute and chronic complications of atherosclerosis 2008 222 0
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways 2008 241 2
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways 2008 287 1
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor 2008 230 81
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability 2008 229 189
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes 2008 255 0
31623 2667